| Study Period | 2021 - 2030 |
| Market Size (2025) | USD 619.70 Billion |
| Market Size (2030) | USD 949.11 Billion |
| CAGR (2025 - 2030) | 8.90 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Medical Devices Reimbursement Market Analysis
The Medical Devices Reimbursement Market size is estimated at USD 619.70 billion in 2025, and is expected to reach USD 949.11 billion by 2030, at a CAGR of 8.9% during the forecast period (2025-2030).
Medical device reimbursement involves insurers compensating healthcare providers for expenses related to medical devices. Key market growth drivers include rising healthcare expenditures, increasing regulatory backing, heightened awareness about healthcare, an aging population, and a surge in chronic and infectious diseases. For instance, data from the Australian Institutes of Health and Welfare in June 2024 highlighted that cardiovascular diseases accounted for almost 12% of the total disease burden, with 14% in males and 10% in females, making it the fourth most significant disease group in 2023. Similarly, a November 2023 report from Deutsches Zentrum für Herz-Kreislaufforschung indicated that Germany sees about 65,000 cardiac arrests annually. Therefore, as healthcare systems pivot towards preventive care, there's a growing focus on medical devices that aid in early disease diagnosis and management. This trend is likely to boost reimbursements for such devices, fueling market growth.
Moreover, an aging population significantly drives up healthcare costs in many countries. A September 2024 study in Discover Social Science and Health highlighted that Japan's healthcare spending has consistently risen by 2% annually over the last 20 years, even as GDP growth remained below 1%. If this trend continues, healthcare spending could eclipse 20% of GDP by 2050. In light of these surging costs, governments globally are launching initiatives to ease the financial burden on patients and encourage health insurance adoption.
Furthermore, governments are revising policies and laws to include medical device costs in healthcare coverage, ensuring patients receive quality care. For instance, in May 2024, the Indian government unveiled the National Health Claims Exchange portal, simplifying the insurance claim process for hospitals nationwide. In March 2024, the United States President passed the Inflation Reduction Act, an extension of the Affordable Care Act (ACA), to lower medical device costs and ensure affordable healthcare. Such initiatives are expected to open new avenues for the medical device reimbursement market in the coming years.
Similarly, in May 2022, the French National Authority for Health endorsed reimbursements for specific medical devices, such as those used in diagnostic imaging and interventional radiology. These proactive steps will likely expand the customer base for health insurance providers, motivating them to develop policies covering medical device costs, thereby driving market growth.
The medical device reimbursement market is poised for growth, given the rising prevalence of chronic diseases, increasing healthcare costs, and strong government support.
However, the complex reimbursement process presents challenges that could temper this growth in the coming years.
Medical Devices Reimbursement Market Trends
Private Segment is Expected to Witness Significant Growth Over the Forecast Period
The private payer segment is expected to grow significantly during the forecast period. The increasing prevalence of chronic diseases, including cardiovascular diseases, cancer, respiratory issues, and diabetes, is driving up healthcare costs as individuals seek better treatments. For instance, data released by the British Heart Foundation in January 2024 highlights that in 2023, about 7.6 million individuals in the United Kingdom had heart or circulatory diseases, and roughly 2.3 million had congestive heart disease (CHD). This significant health burden translates to considerable healthcare expenses, potentially driving growth.
Additionally, healthcare spending rises as chronic and infectious diseases become more prevalent. For instance, a December 2023 fact sheet from the Centers for Medicare & Medicaid Services reveals that 2022 private health insurance expenditures reached USD 1,289.8 billion, a 5.9% increase from the prior year. Concurrently, out-of-pocket costs rose by 6.6%, amounting to USD 471.4 billion. Hospital spending climbed to USD 1,355.0 billion, reflecting a 2.2% increase, while expenditures on physician and clinical services rose by 2.7%, totaling USD 884.9 billion in the United States. These figures underscore the projected strong growth of the private payer segment shortly.
Moreover, a significant portion of the population depends on private health insurance from private payers to access various healthcare services, including medical devices. For instance, an April 2023 study published in Health Policy analyzed claims from over 200,000 private insurance holders in Italy for 2022. Furthermore, a February 2024 article in Feather Insurance highlighted that private insurance covers up to 60% of dental procedures in Germany, including crowns, veneers, onlays, inlays, and bridges. These instances underscore private payers' pivotal role in shaping the reimbursement landscape.
Thus, given the rising prevalence of chronic diseases, the growing dependence on private insurance, and the comprehensive coverage private payers provide for medical device reimbursements, the segment is set for notable growth in the years ahead.
Understand The Key Trends Shaping This Market
Download PDF
North America is Anticipated to Significantly Grow During the Forecast Period
The North American region is poised to grow over the forecast period, owing to factors such as a robust regulatory framework, increasing healthcare spending, and proactive measures from industry players. For instance, the United States Food and Drug Administration (FDA) established the Payor Communication Task Force initiative in June 2024 to enable streamlined conversations between device manufacturers and payors such as the Centers for Medicare & Medicaid Services (CMS). The task force allows manufacturers to participate in the Early Payor Feedback Program. This program aims to reduce the time between FDA clearance and payor coverage determinations so manufacturers can plan their device development accordingly, hopefully expediting patient access. Thus, such initiatives are expected to encourage medical device manufacturers to prepare appropriate reimbursement proposals for regulatory authorities to accelerate the approval process, thereby contributing to market growth over the forecast period.
Furthermore, rising healthcare expenditures, whether public or private, are likely to prompt insurance providers to broaden their service offerings. For instance, data published by the Canadian Medical Association in February 2024 highlighted that Canada’s total health spending was expected to reach USD 344 billion in 2023, or USD 8,740 per Canadian, and more than half of health spending goes to three areas which are hospitals (26%), drugs (14%) and physicians (14%). Moreover, the presence of organizations offering reimbursement for healthcare services is contributing to market growth. For example, the Canadian Association for Healthcare Reimbursement (CAHR) is a not-for-profit, member-supported association representing professionals interested in public and private reimbursement for pharmaceutical and medical devices within the Canadian healthcare system. Thus, with significant healthcare spending and a robust presence of reimbursement entities, the region is set to witness heightened market growth in the coming years.
Moreover, major companies are also pursuing partnerships, mergers, and acquisitions to enhance their offerings and carve out a competitive edge. For instance, in May 2023, Humana Inc. formed a strategic alliance with Rotech Healthcare Inc. and AdaptHealth Corp. to provide durable medical equipment services and support Humana Medicare Advantage HMO members in achieving optimal health at home. Such strategic moves by industry players are anticipated to drive market growth in the forecast period.
Therefore, with the initiatives from regulatory bodies, escalating healthcare expenditures, and strategic maneuvers by market players, the North American region is primed for growth in the medical devices reimbursement market.
Get Analysis on Important Geographic Markets
Download PDF
Medical Devices Reimbursement Industry Overview
The medical devices reimbursement market is fragmented due to the presence of many players operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold considerable market share and are well known. They include Allianz, Anthem Insurance Companies, Inc., UnitedHealthcare, Aetna Inc., Cigna Healthcare, and others. These companies are expanding their offerings and making strategic alliances across various regions to expand their geographical presence and maintain their market position.
Medical Devices Reimbursement Market Leaders
-
Allianz
-
UnitedHealthcare
-
Cigna Healthcare
-
Aetna Inc.
-
Anthem Insurance Companies, Inc.
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Medical Devices Reimbursement Market News
- September 2024: UnitedHealthcare expanded its medical policy on cochlear implants to improve access to hearing services and extend coverage to younger patients in the United States. The updated policy now covers patients aged six months and older with bilateral sensorineural hearing loss (SNHL). It also covers patients nine months and older with single-sided deafness (SSD) or asymmetric SNHL when clinically appropriate.
- June 2024: The Egypt Health Care Authority signed two cooperation protocols: one with Allianz to expand medical services for international patients and address overseas waiting lists, and another with Medtronic to share expertise in training healthcare providers on the latest medical devices and technologies for treating patients in provinces under universal health insurance.
Medical Devices Reimbursement Industry Segmentation
As per the scope of the report, medical devices used during a surgical procedure are typically reimbursed as a part of the payment in healthcare settings. The medical devices reimbursement market is segmented by payer, healthcare settings, and geography. By payer, the market is segmented into public and private. By healthcare settings, the market is segmented into hospitals, outpatient facilities, and others. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD) for above segments.
| By Payer | Public | ||
| Private | |||
| By Healthcare Settings | Hospitals | ||
| Outpatient Facilities | |||
| Others | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Need A Different Region or Segment?
Customize Now
Medical Devices Reimbursement Market Research Faqs
How big is the Medical Devices Reimbursement Market?
The Medical Devices Reimbursement Market size is expected to reach USD 619.70 billion in 2025 and grow at a CAGR of 8.90% to reach USD 949.11 billion by 2030.
What is the current Medical Devices Reimbursement Market size?
In 2025, the Medical Devices Reimbursement Market size is expected to reach USD 619.70 billion.
Who are the key players in Medical Devices Reimbursement Market?
Allianz, UnitedHealthcare, Cigna Healthcare, Aetna Inc. and Anthem Insurance Companies, Inc. are the major companies operating in the Medical Devices Reimbursement Market.
Which is the fastest growing region in Medical Devices Reimbursement Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Medical Devices Reimbursement Market?
In 2025, the North America accounts for the largest market share in Medical Devices Reimbursement Market.
What years does this Medical Devices Reimbursement Market cover, and what was the market size in 2024?
In 2024, the Medical Devices Reimbursement Market size was estimated at USD 564.55 billion. The report covers the Medical Devices Reimbursement Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Medical Devices Reimbursement Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Medical Devices Reimbursement Industry Report
Statistics for the 2025 Medical Devices Reimbursement market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Medical Devices Reimbursement analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
